Virtus ETF Advisers LLC Magenta Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $82,854 - $155,795	-18,703 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $5,887 - $9,593	-970 Reduced 4.93%	18,703 $136,000
Q2 2021 Aug 10, 2021	BUY	$9.76 - $14.15 $192,008 - $278,372	19,673 New	19,673 $192,000
Q4 2019 Feb 13, 2020	SELL	$9.07 - $15.84 $159,622 - $278,768	-17,599 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$9.63 - $14.0 $9,437 - $13,720	-980 Reduced 5.27%	17,599 $181,000
Q2 2019 Aug 13, 2019	BUY	$13.4 - $17.67 $248,958 - $328,290	18,579 New	18,579 $274,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.